SCHEMBL20288221

SCHEMBL20288221

CCC(C)(C)c1ccc(F)c(N(C)C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 4/20 0.40
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ NPSR1 Q6W5P4 3/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 3/20 0.35
▸ RIPK1 Q13546 6/20 0.35
▸ ESR1 P03372 1/20 0.33
▸ POLB P06746 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ HTT P42858 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19240354 0.81 CYP1A2 (0.40) SMN1; SMN2NPC1RAB9ALMNACASP3
SCHEMBL13496391 0.79 NPC1 (0.46) MAPK1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL13320847 0.79 ESR1 (0.46) MAPK1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL9234432 0.77 PDE2A (0.42) SMN1; SMN2
SCHEMBL19225702 0.74 MAPK1 (0.42) MAPK1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL13933403 0.74 NPC1 (0.42) MAPK1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL19251349 0.73 MAPK1 (0.41) MAPK1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL19965714 0.72 MAPK1 (0.43) MAPK1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL20288216 0.71 NPC1 (0.40) MAPK1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL21325078 0.71 CYP1A2 (0.40) MEN1KMT2AALDH1A1MAPTRIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647683-B2 Hsp70 modulators and methods for making and using the same MEMORIAL SLOAN KETTERING CANCER CENTER (US) 2020-05-12 — — US disclosed
US-20190241526-A1 HSP70 MODULATORS AND METHODS FOR MAKING AND USING THE SAME MEMORIAL SLOAN KETTERING CANCER CENTER 2019-08-08 — — US disclosed
US-20180170883-A1 HSP70 MODULATORS AND METHODS FOR MAKING AND USING THE SAME MEMORIAL SLOAN KETTERING CANCER CENTER 2018-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190241526-A1 HSP70 MODULATORS AND METHODS FOR MAKING AND USING THE SAME HSPA2, HSP90AA1, HSP90AB1 MAPK1 3284/4885SMN1; SMN2 288/4885NPC1 3656/4885
US-20180170883-A1 HSP70 MODULATORS AND METHODS FOR MAKING AND USING THE SAME HSPA2, HSP90AA1, HSP90AB1 MAPK1 3284/4885SMN1; SMN2 288/4885NPC1 3656/4885
US-10647683-B2 Hsp70 modulators and methods for making and using the same HSPA2, HSP90AA1, HSP90AB1 MAPK1 3284/4885SMN1; SMN2 288/4885NPC1 3656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback